NASDAQ:ESPR Shareholder Notice: Lawsuit Alleges Misleading Statements by Esperion Therapeutics, Inc
May 22, 2018 at 12:30 PM EDT
San Diego, CA -- (SBWIRE) -- 05/22/2018 -- An investor, who purchased shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR), filed a lawsuit over alleged violations of Federal Securities Laws by Esperion Therapeutics, Inc.
